Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,920 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C, Pritchard-Jones K, Shannon R, Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM, Gornall P, Walker J, Taylor R, Sartori P, Hale J, Levitt G, Messahel B, Middleton H, Grundy R, Pritchard J; United Kingdom Cancer Study Group. Mitchell C, et al. Eur J Cancer. 2006 Oct;42(15):2554-62. doi: 10.1016/j.ejca.2006.05.026. Epub 2006 Aug 10. Eur J Cancer. 2006. PMID: 16904312 Clinical Trial.
Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
Nicolin G, Taylor R, Baughan C, Shannon R, Stevens S, Richardson D, Kelsey A, Pritchard-Jones K, Mitchell C. Nicolin G, et al. Among authors: mitchell c. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):175-80. doi: 10.1016/j.ijrobp.2007.05.053. Epub 2007 Nov 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 17980506
Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K, Kelsey A, Vujanic G, Imeson J, Hutton C, Mitchell C; United Kingdom Children's Cancer Study Group; Wilm's Tumor Working Group. Pritchard-Jones K, et al. Among authors: mitchell c. J Clin Oncol. 2003 Sep 1;21(17):3269-75. doi: 10.1200/JCO.2003.01.062. J Clin Oncol. 2003. PMID: 12947062 Clinical Trial.
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience.
Irtan S, Jitlal M, Bate J, Powis M, Vujanic G, Kelsey A, Walker J, Mitchell C, Machin D, Pritchard-Jones K; Renal Tumours Committee of the Children’s Cancer and Leukaemia Group (CCLG). Irtan S, et al. Among authors: mitchell c. Eur J Cancer. 2015 Jan;51(2):225-32. doi: 10.1016/j.ejca.2014.10.026. Epub 2014 Nov 22. Eur J Cancer. 2015. PMID: 25465191 Clinical Trial.
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, Moorman AV, Wade R. Vora A, et al. Among authors: mitchell c. Lancet Oncol. 2014 Jul;15(8):809-18. doi: 10.1016/S1470-2045(14)70243-8. Epub 2014 Jun 9. Lancet Oncol. 2014. PMID: 24924991 Clinical Trial.
Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study.
Eiser C, Stride CB, Vora A, Goulden N, Mitchell C, Buck G, Adams M, Jenney MEM; National Cancer Research Institute Childhood Leukaemia Sub-Group and UK Childhood Leukaemia Clinicians Network. Eiser C, et al. Among authors: mitchell c. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26615. Epub 2017 May 5. Pediatr Blood Cancer. 2017. PMID: 28475268 Free article. Clinical Trial.
3,920 results